These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23362315)

  • 1. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
    Davis TM; Coleman RL; Holman RR;
    Circulation; 2013 Mar; 127(9):980-7. PubMed ID: 23362315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation.
    Farag AA; AlJaroudi W; Neill J; Doppalapudi H; Kumar V; Rizk D; Iskandrian AE; Hage FG
    Int J Cardiol; 2017 Dec; 249():377-382. PubMed ID: 28958755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors influencing cardiac complications in patients with type-2 diabetes mellitus and silent myocardial ischaemia: five-year follow-up].
    Mamcarz A; Chmielewski M; Braksator W; Syska-Sumńska J; Janiszewski M; Król J; Kuch M; Kuch J; Dłuiniewski M
    Pol Arch Med Wewn; 2004 Dec; 112(6):1433-43. PubMed ID: 15962608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
    Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
    Aguilar D; Solomon SD; Køber L; Rouleau JL; Skali H; McMurray JJ; Francis GS; Henis M; O'Connor CM; Diaz R; Belenkov YN; Varshavsky S; Leimberger JD; Velazquez EJ; Califf RM; Pfeffer MA
    Circulation; 2004 Sep; 110(12):1572-8. PubMed ID: 15364810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.
    Erdmann E; Dormandy JA; Charbonnel B; Massi-Benedetti M; Moules IK; Skene AM;
    J Am Coll Cardiol; 2007 May; 49(17):1772-80. PubMed ID: 17466227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort.
    Tao L; Wilson EC; Griffin SJ; Simmons RK;
    Value Health; 2013; 16(6):1074-80. PubMed ID: 24041358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
    Stevens RJ; Coleman RL; Adler AI; Stratton IM; Matthews DR; Holman RR
    Diabetes Care; 2004 Jan; 27(1):201-7. PubMed ID: 14693990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study.
    Qureshi WT; Zhang ZM; Chang PP; Rosamond WD; Kitzman DW; Wagenknecht LE; Soliman EZ
    J Am Coll Cardiol; 2018 Jan; 71(1):1-8. PubMed ID: 29301615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
    Adler AI; Levy JC; Matthews DR; Stratton IM; Hines G; Holman RR
    Diabet Med; 2005 Mar; 22(3):306-11. PubMed ID: 15717879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up.
    Elliott MD; Heitner JF; Kim H; Wu E; Parker MA; Lee DC; Kaufman DB; Bonow RO; Judd R; Kim RJ
    Diabetes Care; 2019 Jul; 42(7):1290-1296. PubMed ID: 31010876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
    Davis WA; Colagiuri S; Davis TM
    Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery.
    Feringa HH; Karagiannis SE; Vidakovic R; Elhendy A; ten Cate FJ; Noordzij PG; van Domburg RT; Bax JJ; Poldermans D
    Coron Artery Dis; 2007 Nov; 18(7):571-6. PubMed ID: 17925612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelations Between Serum Uric Acid, Silent Myocardial Infarction, and Mortality in the General Population.
    Ahmad MI; Dutta A; Anees MA; Soliman EZ
    Am J Cardiol; 2019 Mar; 123(6):882-888. PubMed ID: 30617009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silent Myocardial Infarction and Long-Term Risk of Frailty: The Atherosclerosis Risk in Communities Study.
    Li F; Li D; Yu J; Jia Y; Liu Y; Liu Y; Wu Q; Liao X; Zeng Z; Wan Z; Zeng R
    Clin Interv Aging; 2021; 16():1139-1149. PubMed ID: 34168437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the UKPDS Outcomes Model 2 for Predicting Death and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus from a German Population-Based Cohort.
    Laxy M; Schöning VM; Kurz C; Holle R; Peters A; Meisinger C; Rathmann W; Mühlenbruch K; Kähm K
    Pharmacoeconomics; 2019 Dec; 37(12):1485-1494. PubMed ID: 31350720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient ischemic dilation in patients with diabetes mellitus: prognostic value and effect on clinical outcome after coronary revascularization.
    Petretta M; Acampa W; Daniele S; Petretta MP; Plaitano M; Cuocolo A
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):908-15. PubMed ID: 24014824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.